Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 8/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.60 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.44 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TK2 | O00142 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2350762 | 1.00 | KIF11 (0.60) | KIF11KCNH2SLC6A1SLC6A11SMN1; SMN2 | |
| SCHEMBL16209506 | 1.00 | KIF11 (0.60) | KIF11KCNH2SLC6A1SLC6A11SMN1; SMN2 | |
| SCHEMBL16353449 | 0.98 | KIF11 (0.61) | KIF11KCNH2SLC6A1SLC6A11SMN1; SMN2 | |
| SCHEMBL20827845 | 0.94 | KIF11 (0.63) | KIF11KCNH2SLC6A1SLC6A11SMN1; SMN2 | |
| SCHEMBL2490823 | 0.88 | KIF11 (0.73) | KIF11KCNH2SLC6A1SLC6A11SMN1; SMN2 | |
| SCHEMBL3617308 | 0.88 | KIF11 (0.73) | KIF11KCNH2SLC6A1SLC6A11SMN1; SMN2 | |
| SCHEMBL2493851 | 0.88 | KIF11 (0.53) | KIF11KCNH2SLC6A11 | |
| SCHEMBL8703547 | 0.87 | KIF11 (0.71) | KIF11KCNH2TK2 | |
| SCHEMBL5819858 | 0.87 | KIF11 (0.47) | KIF11KCNH2SLC6A1SLC6A11TK2 | |
| SCHEMBL18413416 | 0.87 | KIF11 (0.47) | KIF11KCNH2SLC6A1SLC6A11TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009026-A1 | Capped RNA and Method for Producing Same, Apparatus for Producing Protein, and Method for Producing Protein | JAPAN SCIENCE & TECH AGENCY (JP) | 2026-01-08 | — | — | US | disclosed |
| EP-4509608-A1 | CAPPED RNA AND METHOD FOR PRODUCING SAME, APPARATUS FOR PRODUCING PROTEIN, AND METHOD FOR PRODUCING PROTEIN | Japan Science and Technology Agency (JP) | 2025-02-19 | — | — | EP | disclosed |
| EP-1781675-B1 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | EPOCH BIOSCIENCES INC (US) | 2014-03-26 | — | — | EP | disclosed |
| US-8389745-B2 | Phosphonate fluorescent dyes and conjugates | ELITECH HOLDING B.V. (NL) | 2013-03-05 | — | — | US | disclosed |
| US-20120116079-A1 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | ELITECHGROUP MDX LLC | 2012-05-10 | — | — | US | disclosed |
| US-8008522-B2 | Phosphonate fluorescent dyes and conjugates | ELITECH HOLDING B.V. (NL) | 2011-08-30 | — | — | US | disclosed |
| US-20100261903-A1 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | ELITECHGROUP MDX LLC | 2010-10-14 | — | — | US | disclosed |
| US-7767834-B2 | Phosphonylated fluorescent dyes and conjugates | ELITECH HOLDING B.V. (NL) | 2010-08-03 | — | — | US | disclosed |
| US-7671218-B2 | Phosphonate fluorescent dyes and conjugates | Elitech Holdings B.V. (NL) | 2010-03-02 | — | — | US | disclosed |
| US-20080207887-A1 | PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES | EPOCH BIOSCIENCES, INC. (US) | 2008-08-28 | — | — | US | disclosed |
| US-20070172832-A1 | Phosphonate fluorescent dyes and conjugates | EPOCH BIOSCIENCES, INC. (US) | 2007-07-26 | — | — | US | disclosed |
| EP-1781675-A2 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | Epoch Biosciences, Inc. (US) | 2007-05-09 | — | — | EP | disclosed |
| US-20060199955-A1 | Phosphonylated fluorescent dyes and conjugates | EPOCH BIOSCIENCES, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| WO-2006020947-A2 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | EPOCH BIOSCIENCES, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261903-A1 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | PHOSPHO1, PFAS, PHPT1 | KIF11 1337/4885KCNH2 4693/4885SLC6A1 2016/4885 |
| US-20080207887-A1 | PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES | PHOSPHO1, PFAS, PHPT1 | KIF11 1281/4885KCNH2 4519/4885SLC6A1 3320/4885 |
| US-20070172832-A1 | Phosphonate fluorescent dyes and conjugates | PHOSPHO1, PFAS, PHPT1 | KIF11 1337/4885KCNH2 4693/4885SLC6A1 2016/4885 |
| US-20260009026-A1 | Capped RNA and Method for Producing Same, Apparatus for Producing Protein, and Method for Producing Protein | RNGTT, RNMT, NSUN3 | KIF11 1602/4885KCNH2 4106/4885SLC6A1 4216/4885 |
| US-20060199955-A1 | Phosphonylated fluorescent dyes and conjugates | PHOSPHO1, PFAS, PHPT1 | KIF11 1281/4885KCNH2 4519/4885SLC6A1 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.